MEI Pharma, Inc. (MEIP) Financials

MEIP Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 78.5 million 19.1 million
2023-09-30 101.3 million 19.9 million
2023-06-30 120.8 million 96.2 million
2023-03-31 134.2 million 99.8 million

MEIP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -11.1 million 850000
2023-09-30 -18.5 million 363000
2023-06-30 -11.3 million 299000
2023-03-31 -12.1 million 918000

MEIP Net Income

No data available :(

MEIP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 59.5 million - 12.0 million
2023-09-30 82.2 million - 12.4 million
2023-06-30 100.7 million - 12.7 million
2023-03-31 112.0 million - 13.1 million

MEIP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 6.7 million
2023-09-30 6.7 million
2023-06-30 6.7 million
2023-03-31 6.7 million

MEIP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 7000 3.9 million 8.0 million -85000
2023-09-30 7000 3.5 million 6.5 million -
2023-06-30 28000 2.6 million 10.0 million -
2023-03-31 7000 15.1 million 7.2 million -

MEIP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 85000
2023-09-30 65.3 million 459000
2023-06-30 1.5 million 464000
2023-03-31 5.9 million 457000

MEIP

Price: $3.06

52 week price:
3.05
7.97

Payout Ratio Range:
-33.65%
28.36%

Earnings Per Share: 2.98 USD

P/E Ratio: 0.74

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 480786

Ebitda: -6.2 million

Market Capitalization: 21.7 million

Links: